Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1980Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Investigator-initiated clinical trials in the Czech Republic - overview for 2004-2007
Lenka Horavová,Katerina Nebeská,Jana Merhautová,Regina Demlová,Lenka Soucková
Klinická farmakologie a farmacie.2019;32(4)3
[DOI]
2Acceleration of rare disease therapeutic development: a case study of AGIL-AADC
Sonya Das,Samuel Huang,Andrew W. Lo
Drug Discovery Today.2019;24(3)678
[DOI]
3A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-specific clinical success rates
Jonathan Dando,Maximilian Lebmeier
Journal of Innovation and Entrepreneurship.2020;9(1)678
[DOI]
4Cell-Based Therapies for Stroke: Are We There Yet?
Mirja Krause,Thanh G. Phan,Henry Ma,Christopher G. Sobey,Rebecca Lim
Frontiers in Neurology.2019;10(1)678
[DOI]
5Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan
Mitsuhiro Rokuda,Naoki Matsumaru,Katsura Tsukamoto
Clinical Therapeutics.2018;40(2)284
[DOI]
6Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016
Yao Qiao,G Caleb Alexander,Thomas J Moore
Clinical Trials.2019;16(3)329
[DOI]
7Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016
Saisai Wang
Clinical Trials.2020;5(3)81
[DOI]
8Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
Teodora Lalova,Cristina Padeanu,Anastassia Negrouk,Denis Lacombe,Jan Geissler,Ingrid Klingmann,Isabelle Huys
Frontiers in Medicine.2020;7(3)81
[DOI]
9Regulations and Guidelines for Planning and Design of Multi-regional Clinical Trials
Yun-Kyoung Song,Minji Sohn,Ah Young Jeon,Jae Hyun Kim,Eunhee Ji,Jung Mi Oh,In-Wha Kim
Korean Journal of Clinical Pharmacy.2018;28(2)146
[DOI]
10Strategic inclusion of regions in multiregional clinical trials
Seung Yeon Song,Deborah Chee,EunYoung Kim
Clinical Trials.2019;16(1)98
[DOI]
11Perspectives on Adopting the Guideline for Multi-regional Clinical Trials in Korea: A Multi-stakeholder Survey
Minji Sohn,Yun-Kyoung Song,Ah Young Jeon,Jung Mi Oh,In-Wha Kim
Korean Journal of Clinical Pharmacy.2019;29(4)267
[DOI]
12Hierarchical Generalized Linear Models for Multiregional Clinical Trials
Junhui Park,Seung-Ho Kang
Statistics in Biopharmaceutical Research.2021;29(4)1
[DOI]
13Hierarchical Generalized Linear Models for Multiregional Clinical Trials
Basant Amarji,Sara Nidal Abed,Ujjawal Bairagi,Pran Kishore Deb,Omar Al-Attraqchi,Anup Avijit Choudhury,Rakesh K. Tekade
Statistics in Biopharmaceutical Research.2018;29(4)637
[DOI]
14The progression of clinical trials in Indonesia: an observational study of records from clinical trial registries databases
Marlinang Diarta Siburian,Sifa Marie Joelle Muchanga,Antonio Fredelindo Dela Resma Villanueva,Rianto Setiabudy,Iiyama Tatsuo
Global Health Journal.2020;4(3)87
[DOI]
15Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited
Dario Tedesco,Mufiza Farid-Kapadia,Martin Offringa,Zulfiqar A. Bhutta,Yvonne Maldonado,John P.A. Ioannidis,Despina G. Contopoulos-Ioannidis
Journal of Clinical Epidemiology.2018;95(3)63
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal